INV-721

N/A

Report date: 2023/01/07 19:50:56

Base Information

Drug NameINV-721

Drug Alias NameINV-721

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionImmunomodulatorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsAnti-GD2 +[4]

TargetsDisialoganglioside GD2CD276 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInvenra Inc

China Registration ClassN/A

Develop Information

Active CompaniesInvenra Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A